NORRISTOWN, Pa., Aug. 4, 2026 /PRNewswire-PRWeb/ — Maxx Orthopedics Expands Freedom® PCK® Revision Knee System with Launch of PCK® Metaphyseal Cones
Maxx Orthopedics Expands Freedom® PCK® Revision Knee System with Launch of PCK® Metaphyseal Cones
2 min read Premium comments
commercial launchMaxx OrthopedicsPCK Metaphyseal ConesFreedom® Titan PCK® Revision Knee Systemrevision total knee arthroplasty
Maxx Orthopedics, Inc., a rapidly expanding global orthopedic device company, today announces the commercial launch of PCK® Metaphyseal Cones – porous titanium tibial cones engineered for complex revision total knee arthroplasty (TKA).
The PCK® Metaphyseal Cones integrate seamlessly with both the Freedom® PCK® (Progressive Constraint Kinematics) Revision Knee System and the Freedom® Titan PCK® Revision Knee System, designed for patients with metal sensitivities – giving surgeons a complete, unified solution for even the most demanding revision cases.
Made from Ti6Al4V ELI titanium alloy, the PCK® Cones feature a 3D-printed lattice structure that replicates the porosity of cancellous bone, promoting durable long-term metaphyseal fixation. A stepped outer geometry resists subsidence and rotational loosening, while the keel relief slots enable independent, optimized positioning of the Freedom® PCK Tibial Baseplate without over-constraint of the cone’s geometry.
Key system features:
• 3D-Printed Porous Scaffold — Promotes durable cementless fixation and addresses bone defects presented in revision surgery.
• Stepped External Geometry — Resists subsidence and rotational loosening for dependable support in compromised tibial bone.
• Seven Size Options — Accommodates a wide range of defect sizes with intraoperative rotational flexibility.
“PCK Cones complete our revision knee offering, giving surgeons the stable metaphyseal scaffold they need for addressing bone defects, while maintaining the surgical simplicity and reliability the Freedom Knee platform is known for.”
— Farzin Khaghani, Chief Commercial Officer, Maxx Orthopedics
PCK® Metaphyseal Cones are now available in the United States. Visit https://www.maxxortho.com or contact your local Maxx Orthopedics representative for more information.
About Maxx Orthopedics, Inc.
Maxx Orthopedics, Inc. is the manufacturer of the Freedom® Knee System, Libertas® Total Hip System, Keystone™ Hip System, and Quick Recovery Solutions (QRS®). We develop and market innovative orthopedic medical devices with a focus on providing state-of-the-art implants and related solutions designed to best restore patient mobility, while accommodating lifestyle, anatomical, and economic needs. Find out more at www.maxxortho.com and follow us on LinkedIn, X, Instagram, and Facebook.
Media Contact
Hillary Berenato| Maxx Orthopedics, Inc.| (484) 571-7909 | hillary.berenato@maxxortho.com https://www.maxxortho.com
SOURCE Maxx Orthopedics, Inc.
Why This Matters
Two Perspectives
MBA Lens: Economic and industry impact
Maxx Orthopedics commercially launched PCK® Metaphyseal Cones, expanding its Freedom® PCK® Revision Knee System. This strategic move aims to offer a complete, unified solution for complex revision total knee arthroplasty, enhancing the company's competitive position. The cones integrate with existing systems, including those for metal-sensitive patients, streamlining surgical options and potentially boosting market adoption in the demanding revision TKA segment.
- The launch completes Maxx Orthopedics' revision knee offering, providing a stable metaphyseal scaffold for bone defects.
- The product's availability in the U.S. strengthens the company's portfolio in the complex revision TKA market.
PhD Lens: Clinical and outcomes impact
Maxx Orthopedics introduced PCK® Metaphyseal Cones, porous titanium tibial cones for complex revision total knee arthroplasty. These cones, made from Ti6Al4V ELI titanium alloy, feature a 3D-printed lattice structure mimicking cancellous bone to promote durable cementless metaphyseal fixation. Their stepped outer geometry is engineered to resist subsidence and rotational loosening, while keel relief slots allow optimized baseplate positioning.
- The 3D-printed porous scaffold is designed to address bone defects and promote long-term fixation.
- The system offers seven size options and rotational flexibility, but no clinical evidence or outcomes are presented.
React:
Discussion
This is a fascinating development. In my practice we've seen similar outcomes with the revised protocol. The key differentiator seems to be patient selection criteria. Has anyone else noticed the correlation with BMI thresholds?
Great point. I'd push back slightly on the conclusion, the sample size in the cited study is too small to draw population-level inferences. That said, the directional signal is compelling and worth a larger RCT.
We implemented a similar approach last year. Early results are promising but we're still gathering 12-month follow-up data. Happy to share our protocol if anyone is interested.
Join the conversation
Orthopedic professionals are discussing this. Sign in and upgrade to read every comment and add your voice.